Jane Street Group, LLC Rocket Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 177,672 shares of RCKT stock, worth $2.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

177,672

Previous 130,538 36.11%

Holding current value

$2.51 Million

Previous $2.81 Million 16.76%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$17.6 - $25.88 $829,558 - $1.22 Million	47,134 Added 36.11%	177,672 $3.28 Million
Q2 2024 Aug 14, 2024	BUY	$20.66 - $26.72 $2.7 Million - $3.49 Million	130,538 New	130,538 $2.81 Million
Q4 2023 Feb 14, 2024	BUY	$16.78 - $31.94 $207,283 - $394,554	12,353 Added 34.61%	48,048 $1.44 Million
Q3 2023 Nov 14, 2023	SELL	$15.07 - $24.05 $1.52 Million - $2.43 Million	-101,146 Reduced 73.91%	35,695 $731,000
Q2 2023 Aug 14, 2023	BUY	$16.59 - $23.6 $1.86 Million - $2.65 Million	112,289 Added 457.35%	136,841 $2.72 Million
Q1 2023 May 15, 2023	BUY	$15.79 - $22.6 $127,883 - $183,037	8,099 Added 49.23%	24,552 $420,000
Q4 2022 Feb 14, 2023	BUY	$15.5 - $22.76 $79,158 - $116,235	5,107 Added 45.01%	16,453 $321,000
Q3 2022 Nov 14, 2022	SELL	$12.37 - $18.41 $20,410 - $30,376	-1,650 Reduced 12.7%	11,346 $181,000
Q3 2022 Nov 14, 2022	SELL	$12.37 - $18.41 $20,410 - $30,376	-1,650 Reduced 12.7%	11,346 $181,000
Q2 2022 Aug 16, 2022	BUY	$7.96 - $16.64 $103,448 - $216,253	12,996 New	12,996 $179,000
Q1 2022 May 17, 2022	SELL	$13.16 - $23.68 $143,773 - $258,704	-10,925 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$21.52 - $36.02 $14,203 - $23,773	660 Added 6.43%	10,925 $239,000
Q3 2021 Nov 16, 2021	BUY	$27.42 - $48.97 $147,437 - $263,311	5,377 Added 110.0%	10,265 $307,000
Q2 2021 Aug 16, 2021	SELL	$39.41 - $47.25 $564,705 - $677,045	-14,329 Reduced 74.56%	4,888 $216,000
Q1 2021 May 18, 2021	SELL	$43.34 - $65.91 $65,790 - $100,051	-1,518 Reduced 7.32%	19,217 $853,000
Q4 2020 Feb 17, 2021	BUY	$23.3 - $59.57 $20,550 - $52,540	882 Added 4.44%	20,735 $1.14 Million
Q3 2020 Nov 17, 2020	BUY	$20.5 - $28.59 $406,986 - $567,597	19,853 New	19,853 $454,000

Others Institutions Holding RCKT

# of Institutions

209

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.07B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Rocket Pharmaceuticals, Inc. Transaction History